Explore " randomized controlled trials" with insightful episodes like "Next Steps in Development of Mesenchymal Stem Cells as Possible Therapeutic for Kidney Disease", "tHEORetically speaking: Causal Inference In Real-World Healthcare Data", "tHEORetically speaking: Real-World Evidence and Neonatal Outcomes", "Lowering GFR to Protect GFR!" and "Are patient reported outcomes consistent?" from podcasts like ""Journal of the American Society of Nephrology (JASN)", "tHEORetically speaking", "tHEORetically speaking", "Journal of the American Society of Nephrology (JASN)" and "The Lancet Oncology in conversation with"" and more!
In this episode of tHEORetically Speaking, join Michael Grabner, Alexander Turchin, and Shivani Pandya as they answer questions on causal inference and designing these studies using real-world healthcare data.
In this episode of tHEORetically Speaking, join Eric Stanek, Michael Grabner, Deb Discenza, Jennifer Degl, and Thomas Miller as they answer questions on improving neonatal outcomes using Real World Evidence (RWE).
To learn more, click here.
A review in The Lancet Oncology asks whether patient reported outcomes in RCTs are consistent across their analysis, reporting, and interpretation. Author Madeline Pe discusses the findings.
Continue this conversation on social!
Follow us today at...
https://twitter.com/thelancet & https://Twitter.com/TheLancetOncol
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv
Stay up to date
For any inquiries, please email us at hello@podcastworld.io